BMI View: Plans to roll over reserves from pharmaceutical expenditure to cover NFZ deficits are not longterm solutions to the chronic underfunding of the Polish healthcare system. While the NFZ has made savings on medicine reimbursements, it is Polish patients who have borne the cost of those spending cuts. With Polish citizens already spending a significant proportion of their income on healthcare, we believe that provisions for private health insurance to bridge gaps in coverage should be rolled out rapidly. Headline Expenditure Projections ? Pharmaceuticals: PLN31.37bn (US$9.64bn) in 2012 to PLN31.76bn (US$10.06bn) in 2013; 1.3% in local currency terms and …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113342.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/poland-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment